Baseline clinical characteristics of the stroke patients
| N=140 | |
| National Institute of Health Stroke Scale | |
| Admittance to hospital, median (min–max) | 2 (0–24) |
| Discharge from the acute care unit, median (min–max) | 1 (0–13) |
| Glasgow Coma Scale | |
| Admittance to hospital, median (min–max) | 15 (10–15) |
| Discharge from the acute care unit, median (min–max) | 15 (10–15) |
| Aetiology by TOAST | |
| Large-artery atherosclerosis, N (%) | 36 (25.7) |
| Cardioembolism, N (%) | 31 (22.1) |
| Small-artery occlusion, N (%) | 29 (20.7) |
| Other determined, N (%) | 15 (10.7) |
| Undetermined, N (%) | 29 (20.7) |
| Lesion location | |
| Frontal, N (%) | 6 (4.3) |
| Parietal, N (%) | 8 (5.7) |
| Temporal, N (%) | 7 (5.0) |
| Occipital, N (%) | 10 (7.1) |
| Basal ganglia, N (%) | 37 (26.4) |
| More than one location, N (%) | 42 (30.0) |
| Lesion size | |
| <1.5 cm, N (%) | 58 (41.4) |
| 1.5–4.0 cm, N (%) | 29 (20.7) |
| >4.0 cm, N (%) | 23 (16.4) |
| Lesion side | |
| Left, N (%) | 53 (37.9) |
| Right, N (%) | 49 (35.0) |
| Bilateral, N (%) | 8 (5.7) |
| Lesion not visible, N (%) | 30 (21.4) |
| Barthel Index, median (min–max) | 100 (25–100) |
TOAST, Trial of Org 10 172 in acute stroke treatment.